Personalis Inc (PSNL)

NASDAQ

$13.34

Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.

Sector:

Industry:

68 analysts

Buy

Target: $13.29 (-0.37%)

Market Cap

$1.65B

Free Cash Flow Yield

-5.12%

Beta (5Y)

2.30

Adjust inflation

Log

Valuation

Market Cap$1.65B

P/S25.63

P/B6.18

Profitability

Total Revenue (TTM)$65M

Gross Profit (TTM)$8.85M

EBITDA-$93M

Profit Margin-148.1%

Operating Margin-207.9%

EPS-$0.99

Financial Health

Free Cash Flow Yield-5.12%

Growth & Risk

EPS 5Y CAGR-3.14%

Revenue 5Y CAGR-4.30%

FCF 5Y CAGR+11.39%

Beta (5Y)2.30

Sharpe Ratio1.20